These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 9377621)
1. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials. Kong SX; Crawford SY; Gandhi SK; Seeger JD; Schumock GT; Lam NP; Stubbings J; Schoen MD Clin Ther; 1997; 19(4):778-97. PubMed ID: 9377621 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain. Plans-Rubió P Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391 [TBL] [Abstract][Full Text] [Related]
3. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Jones P; Kafonek S; Laurora I; Hunninghake D Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
6. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Pincus J Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683 [No Abstract] [Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal. Pedersen TR; Tobert JA Drug Saf; 1996 Jan; 14(1):11-24. PubMed ID: 8713485 [TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d. Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301 [TBL] [Abstract][Full Text] [Related]
10. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462 [TBL] [Abstract][Full Text] [Related]
11. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS). Smith DG; McBurney CR Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031 [TBL] [Abstract][Full Text] [Related]
12. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis. Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264 [TBL] [Abstract][Full Text] [Related]
13. Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic. Kellick KA; Burns K; McAndrew E; Haberl E; Hook N; Ellis A Am J Cardiol; 1995 Jul; 76(2):62A-64A. PubMed ID: 7604801 [TBL] [Abstract][Full Text] [Related]
14. A review of clinical trials comparing HMG-CoA reductase inhibitors. Illingworth DR; Tobert JA Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304 [TBL] [Abstract][Full Text] [Related]
15. Meeting national cholesterol education goals in clinical practice--a comparison of lovastatin and fluvastatin in primary prevention. Nash DT Am J Cardiol; 1996 Sep; 78(6A):26-31. PubMed ID: 8875972 [TBL] [Abstract][Full Text] [Related]
16. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798 [TBL] [Abstract][Full Text] [Related]
17. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group. Jacotot B; Benghozi R; Pfister P; Holmes D Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial. Zavoral JH; Haggerty BJ; Winick AG; Bergmann SD Am J Cardiol; 1995 Jul; 76(2):37A-40A. PubMed ID: 7604795 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias. Yee HS; Fong NT Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596 [TBL] [Abstract][Full Text] [Related]
20. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Andrews TC; Ballantyne CM; Hsia JA; Kramer JH Am J Med; 2001 Aug; 111(3):185-91. PubMed ID: 11530028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]